Cell culture-derived influenza vaccines in the severe 2017–2018 epidemic season: a step towards improved influenza vaccine effectiveness

Update: Influenza Activity in the United States During the 2017–18 Season and Composition of the 2018–19 Influenza Vaccine

(2018) Rebecca Garten et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Update: Influenza Activity — United States, October 1, 2017–February 3, 2018

(2018) Alicia P. Budd et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Interim Estimates of 2017–18 Seasonal Influenza Vaccine Effectiveness — United States, February 2018

(2018) Brendan Flannery et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017

(2017) Lasse S Vestergaard et al.   Eurosurveillance

Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012–2013 and 2013–2014

(2017) David K. Shay et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older

(2017) Lisa M. Dunkle et al.   NEW ENGLAND JOURNAL OF MEDICINE

Improving the selection and development of influenza vaccine viruses – Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18–20 November 2015

(2017) Alan Hampson et al.   VACCINE

Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014–2015

(2016) Brendan Flannery et al.   JOURNAL OF INFECTIOUS DISEASES

Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies

(2016) Edward A Belongia et al.   LANCET INFECTIOUS DISEASES

Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis

(2015) Hector S Izurieta et al.   LANCET INFECTIOUS DISEASES

Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review

(2014) Sheena G Sullivan et al.   Expert Review of Vaccines

Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturing

(2014) Ruben O. Donis et al.   VACCINE

Surface modifications of influenza proteins upon virus inactivation by β-propiolactone

(2013) Yi-Min She et al.   PROTEOMICS

Oil-in-Water Emulsion Adjuvant with Influenza Vaccine in Young Children

(2011) Timo Vesikari et al.   NEW ENGLAND JOURNAL OF MEDICINE

Isolation of influenza viruses in MDCK 33016PF cells and clearance of contaminating respiratory viruses

(2011) Bernhard Roth et al.   VACCINE

Validation of the safety of MDCK cells as a substrate for the production of a cell-derived influenza vaccine

(2010) David Onions et al.   BIOLOGICALS

Clinical Efficacy of Cell Culture–Derived and Egg‐Derived Inactivated Subunit Influenza Vaccines in Healthy Adults

(2010) Sharon Frey et al.   CLINICAL INFECTIOUS DISEASES

Effect of inactivation method on the cross-protective immunity induced by whole 'killed' influenza A viruses and commercial vaccine preparations

(2010) Y. Furuya et al.   JOURNAL OF GENERAL VIROLOGY

Preclinical and Clinical Development of Plant-Made Virus-Like Particle Vaccine against Avian H5N1 Influenza

(2010) Nathalie Landry et al.   PLoS One

The impact of key amino acid substitutions in the hemagglutinin of influenza A (H3N2) viruses on vaccine production and antibody response

(2010) Zhongying Chen et al.   VACCINE

Current challenges in implementing cell-derived influenza vaccines: Implications for production and regulation, July 2007, NIBSC, Potters Bar, UK

(2009) Philip D. Minor et al.   VACCINE